HCA Healthcare, Inc.

HCA Healthcare, Inc.

HCA

$462.86

Updated: 04/11/2026, 07:59:31

Market Cap
$96.69B
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US

No historical data available

Company Profile

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

USD
NYSE
CEO: Samuel N. Hazen
Employees: 320,000
https://www.hcahealthcare.com
Asset Summaries
Latest generated summaries for HCA

No summaries found.

Detailed business
Evidence-backed facts extracted from the latest official annual filing.
HCA-10-k-fy2025.html5.2 MBtext/htmlENFiled 10/02/2026Period ended 31/12/2025

Business monitoring

Reported and calculated KPIs plus operational exposure disclosed in the FY 2025 filing.

Evidence-backed · 39 KPI observations

Revenue

N/A

FY — · Reported

Net income

6.8B

FY 2025 · Reported

Gross margin

N/A

FY — · Reported

Free cash flow

7.7B

FY 2025 · Calculated

R&D intensity

N/A

FY — · Reported

Share repurchases

10.1B

FY 2025 · Reported

Earnings and cash generation
USD billions, directly sourced from inline XBRL; free cash flow is operating cash flow less capex.
Profitability and reinvestment
Margins and R&D as a percentage of revenue.
Top products and services
Products and services mentioned in the filing; a quantitative sales breakdown was not disclosed.

Other offerings mentioned without separate sales

Outpatient and behavioral service families
General acute care hospital services

Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.

Geographic footprint
What the filing identifies, separated by location role so partner manufacturing is not presented as Apple-owned factories.
1 named headquarters
0 manufacturing countries
0 individually named factories

Map layer

Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.

No reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosure
Named headquarters Manufacturing partner country

Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.

How the business makes money

Company overview

190 hospitals (179 general acute care, 7 behavioral, 4 rehab), 121 ASCs, 31 endoscopy centers; 19 states and England; NYSE: HCA

98%
Source evidence
“At December 31, 2025, we operated 190 hospitals, comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. In addition, we operated 121 freestanding ambulatory surgery centers (“ASCs”) and 31 freestanding endoscopy centers. Our facilities are located in 19 states and England.”

Government program payer mix

45.4% of 2025 revenues derived from Medicare and Medicaid programs

98%
Source evidence
“Specifically, we derived 45.4% of our revenues from the Medicare and Medicaid programs in 2025.”

Private third-party payer revenue share

Revenues derived from private third-party payers (domestic only): 48.9% (2025), 49.5% (2024), 49.0% (2023)

97%
Source evidence
“Revenues derived from private third-party payers (domestic only) accounted for 48.9%, 49.5% and 49.0% of our revenues for 2025, 2024 and 2023, respectively.”

Managed care and payer contracting dynamics

Revenue depends on third-party payer contracts; payer consolidation and narrow networks increase bargaining pressure

92%
Source evidence
“the trend toward consolidation among private third-party payers tends to increase payer bargaining power over fee structures, and private third-party payers may increasingly demand reduced fees or be unwilling to negotiate reimbursement increases.”

Outpatient and behavioral service families

Outpatient network (ASCs, freestanding ER, urgent care, clinics, home health, hospice) plus behavioral health inpatient/outpatient programs

95%
Source evidence
“Our behavioral hospitals provide therapeutic programs, including child, adolescent and adult psychiatric care and adolescent and adult alcohol and drug abuse treatment and counseling.”

General acute care hospital services

Full-range acute care: inpatient, ICU, cardiac, diagnostic, emergency plus outpatient surgery, lab, radiology, PT

95%
Source evidence
“Our general, acute care hospitals typically provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.”

Medicaid state directed and supplemental payment program revenues

Revenues from Medicaid state directed and supplemental payment programs: approximately $6.2 billion (2025) and $5.5 billion (2024)

96%
Source evidence
“Our revenues from Medicaid state directed and supplemental payment programs totaled approximately $6.2 billion and $5.5 billion in 2025 and 2024, respectively.”

Operations and dependencies

Florida and Texas concentration

Facilities heavily concentrated in Florida and Texas

96%
Source evidence
“Our facilities are heavily concentrated in Florida and Texas, which makes us sensitive to regulatory, economic, public health, environmental and competitive conditions and changes in those states.”

Positioning and strategy

New EHR platform implementation

Implementing a new EHR platform across facilities for care coordination, interoperability and cost savings

93%
Source evidence
“we are implementing a new EHR platform across our facilities that is designed to help improve care coordination, enhance data integrity and interoperability, and drive operating efficiencies and cost savings.”

Physician alignment as key competitive factor

Physician number/quality cited as one of two most significant competitive factors

93%
Source evidence
“Two of the most significant factors that impact the competitive position of a hospital are the number and quality of physicians affiliated with or employed by the hospital.”

Growth agenda

Six-point growth agenda including existing-market growth, physician recruitment, disciplined development, and digital/AI advancement

95%
Source evidence
“•advance our digital and artificial intelligence (“AI”) capabilities.”

Growth strategy: existing markets and outpatient expansion

Grow presence in existing markets via physician recruitment and comprehensive service lines (cardiology, neurology, oncology, orthopedics, women's services) plus outpatient network expansion

94%
Source evidence
“developing comprehensive service lines such as cardiology, neurology, oncology, orthopedics and women's services. Additional components of our growth strategy include providing access and convenience through developing various outpatient facilities, including, but not limited to surgery centers, urgent care clinics, freestanding emergency care facilities, imaging centers and home health and hospice services”

Risks, financing, and outlook

Uncompensated care cost increase

Estimated cost of total uncompensated care increased $239 million in 2025 vs 2024; uninsured admissions +1.9% consolidated, ER visits -0.6%

95%
Source evidence
“The estimated cost of total uncompensated care increased $239 million for 2025, compared to 2024. Consolidated and same facility uninsured admissions increased 1.9% and 1.2%, respectively”

Total indebtedness at Dec 31, 2025

Total indebtedness of $46.492 billion as of December 31, 2025

98%
Source evidence
“As of December 31, 2025, our total indebtedness was $46.492 billion.”

Credit facility availability and commercial paper program

$5.779 billion available under senior unsecured credit facility; CP program outstanding $2.207 billion as of Dec 31, 2025

97%
Source evidence
“we had availability of $5.779 billion under our senior unsecured credit facility (after giving effect to all issued and outstanding letters of credit and our intention to maintain a minimum available borrowing capacity equal to the aggregate amount outstanding under the commercial paper program ($2.207 billion as of December 31, 2025))”

Interest expense increase from higher average debt

Interest expense $2.248B (2025) vs $2.061B (2024), +$187 million primarily due to higher average debt balance

96%
Source evidence
“Interest expense totaled $2.248 billion for 2025, compared to $2.061 billion for 2024. The $187 million increase in interest expense for 2025 was primarily due to an increase in the average debt balance.”

Key forward-looking uncertainties

Management flags EPTC expiration (end of 2025), FBA, tariffs, labor/pharma/supply chain pressures, Medicaid payment program changes, sequestration, cybersecurity and weather risks

93%
Source evidence
“including the expiration at the end of 2025 of enhanced premium tax credits ("EPTCs") for eligible individuals purchasing insurance coverage through federal and state-based health insurance marketplaces, changes in the structure and administration of, and funding for, federal and state agencies and programs, and effects of the 2025 Federal Budget Act (the "FBA")”

Medicare sequestration through FY2033

2% Medicare sequestration payment reduction extends through first five months of federal fiscal year 2033

96%
Source evidence
“Congress established automatic spending reductions, referred to as sequestration, under the BCA, resulting in a 2% reduction in Medicare payments that extends through the first five months of federal fiscal year 2033.”

Fraud and abuse laws governing physician financial relationships

Financial relationships with referral sources governed by Anti-kickback Statute, EKRA, Stark Law, FCA, No Surprises Act; some arrangements lack safe harbor protection

93%
Source evidence
“Among these laws are the federal Anti-kickback Statute, EKRA, the federal Stark Law, the FCA, the No Surprises Act and similar state laws.”

Certificate of need and Medicare enrollment regulation

CON laws, 36 Month Rule, CMS enrollment/revocation authority, accreditation, DEA controls, price transparency mandates

93%
Source evidence
“State certificate of need (“CON”) laws, which place limitations on a health care facility’s ability to expand services and facilities, make capital expenditures and otherwise make changes in operations, may also have the effect of restricting competition.”

FBA Medicaid reforms including SDP caps

FBA imposes Medicaid eligibility limits, financing restrictions, and SDP rate caps tied to Medicare rates, expected to impact many states including Texas

93%
Source evidence
“a change that we anticipate will impact payment rates in many states in which we operate, including Texas”

340B payment reductions under outpatient PPS

Additional 340B-related outpatient PPS payment reductions took effect in calendar year 2026 and will continue for several years

92%
Source evidence
“additional reductions to payments for non-drug item and services took effect in calendar year 2026 and will continue for several years, until the past invalidated payments are offset”

Hurricanes Helene and Milton impact

2024 results included ~$250 million ($0.73/diluted share) of expenses and revenue losses from Hurricanes Helene and Milton in North Carolina and Florida

95%
Source evidence
“additional expenses and losses of revenues estimated at approximately $250 million, or $0.73 per diluted share, related to Hurricanes Helene and Milton, which impacted our facilities in North Carolina and certain facilities in Florida”

Clinical workforce and physician staffing risk

Nursing shortage, staffing competition, labor union activity, and physician recruitment/retention risk

95%
Source evidence
“Our results of operations may be adversely affected by competition for staffing, the shortage of experienced nurses and other health care professionals and labor union activity.”

Nurse and healthcare labor shortage risk

Labor shortages of nurses and healthcare professionals may raise labor costs; unionization and strikes possible

95%
Source evidence
“Our results of operations may be adversely affected by competition for staffing, the shortage of experienced nurses and other health care professionals and labor union activity.”

Significant indebtedness

Significant indebtedness; refinancing risk; debt agreements contain restrictive covenants

95%
Source evidence
“Our debt agreements contain restrictions that limit our flexibility in operating our business.”

Risk of declining private insurance enrollment

Recent developments may reduce volumes of privately insured patients, driven by EPTC expiration, FBA provisions, and a June 2025 CMS final rule on the Exchanges

95%
Source evidence
“We anticipate that several recent developments may adversely affect our revenues by contributing to potential future declines in our volume of patients with private health insurance coverage, including the expiration of enhanced premium tax credits, provisions of the FBA that are expected to impact coverage obtained through the Exchanges, and a final rule issued by CMS in June 2025 focused on affordability, consumer protections and integrity of the Exchanges.”

Interest rate risk on variable rate debt

Indebtedness exposes company to interest rate risk on variable rate debt and refinancing risk

95%
Source evidence
“expose us to interest rate risk to the extent of our variable rate debt and prevent us from meeting our obligations”

Physician recruitment and retention risk

Performance depends on recruiting/retaining quality physicians; retirement wave and immigration policy may worsen shortages

93%
Source evidence
“We anticipate facing increased challenges with recruitment and retention as a significant portion of the current physician population reaches retirement age”

Payer consolidation and bargaining power

Payer consolidation, discounted fee demands, narrow/tiered networks, price transparency rules and competitor exclusivity provisions pressure contract terms

93%
Source evidence
“Private third-party payers, including managed care plans and payers participating in the Exchanges, continue to demand discounted fee structures, and the ongoing trend toward consolidation among payers tends to increase their bargaining power over fee structures.”

Cybersecurity and data privacy risk

Cybersecurity/data breach risk including potential patient harm, litigation, regulatory inquiries, and EHR implementation risk

93%
Source evidence
“Failure to effectively manage change associated with our technology, resiliency and other initiatives, including with respect to the implementation of a new electronic health record (“EHR”) platform, may adversely affect our business, services and results of operations.”

Hurricane and natural disaster exposure

Exposure to hurricanes, extreme weather and natural disasters

93%
Source evidence
“Our business and operations are subject to risks related to hurricanes, extreme weather events or other natural disasters.”

Mandatory nurse-staffing ratio regulation

Operating in states with mandatory nurse-staffing ratios; broader adoption could significantly affect labor costs

92%
Source evidence
“We operate in states that have adopted mandatory nurse-staffing ratios or mandate staffing committees to develop staffing plans.”

Significant indebtedness refinancing risk

Forward-looking risk factor: impact of significant indebtedness and ability to refinance on acceptable terms

90%
Source evidence
“(3) the impact of our significant indebtedness and the ability to refinance such indebtedness on acceptable terms”

Site-neutral payment and rate-setting proposals

Site-neutral payment policies and state hospital rate-setting measures could reduce reimbursement

90%
Source evidence
“site-neutral payment policies, which may reduce the reimbursement we receive. Some states are considering or have imposed rate-setting measures, including limits on hospital rates.”

Tariffs and trade policy risk to supply chain

Changes in trade policy and new or increased tariffs may impact supply chain operations

88%
Source evidence
“These may include changes to trade policy and new or increased tariffs, which may impact our supply chain operations.”

Material exposure graph

Medicare and Medicaid
Customer Exposure

45.4% of 2025 revenues come from Medicare/Medicaid, exposing revenue to reimbursement changes such as sequestration and FBA Medicaid reforms.

Relevance 95·Dependency 90·Confidence 98
Source evidence
“we derived 45.4% of our revenues from the Medicare and Medicaid programs in 2025”
Private third-party payers (HMOs, PPOs, managed care plans)
Customer Exposure

Nearly half of domestic revenues come from private third-party payers who reimburse at higher rates than government programs; payer consolidation and network design pressure contract terms.

Relevance 95·Dependency 85·Confidence 96
Source evidence
“Revenues derived from private third-party payers (domestic only) accounted for 48.9%, 49.5% and 49.0% of our revenues for 2025, 2024 and 2023, respectively.”
Nurse and healthcare labor shortage
Cost Driver

Nurse/clinician shortages and union activity drive wage increases, contract labor costs, and capacity constraints; fixed reimbursement rates limit ability to offset.

Relevance 90·Dependency 80·Confidence 94
Source evidence
“We may be required to increase wages and benefits to recruit and retain nurses and other medical support personnel and to hire more expensive temporary or contract personnel.”
FBA Medicaid reforms
Regulatory Exposure

FBA Medicaid eligibility limits, financing restrictions, and SDP rate caps tied to Medicare rates could reduce Medicaid revenues in many states including Texas.

Relevance 90·Dependency 75·Confidence 93
Source evidence
“The FBA requires HHS to revise regulations governing SDP arrangements to cap total payment rates paid by Medicaid managed care organizations for specified services, tying caps to Medicare payment rates instead of average commercial rates”
Texas
Revenue Exposure

Heavy facility concentration in Texas creates state-specific regulatory, economic and competitive sensitivity.

Relevance 85·Dependency 80·Confidence 90
Source evidence
“Our facilities are heavily concentrated in Florida and Texas, which makes us sensitive to regulatory, economic, public health, environmental and competitive conditions and changes in those states.”
Florida
Revenue Exposure

Heavy facility concentration in Florida and Texas makes results sensitive to regulatory, economic, public health, environmental and competitive changes in those states, and to hurricanes/extreme weather.

Relevance 85·Dependency 80·Confidence 90
Source evidence
“Our facilities are heavily concentrated in Florida and Texas, which makes us sensitive to regulatory, economic, public health, environmental and competitive conditions and changes in those states.”
Medicare and Medicaid programs
Revenue Exposure

Changes in government health care programs may adversely affect revenues; loss of Medicare/Medicaid certification would make a facility unable to receive federal health care program reimbursement.

Relevance 85·Dependency 75·Confidence 88
Source evidence
“If any facility were to lose its Medicare or Medicaid certification, the facility would be unable to receive reimbursement from applicable federal health care programs.”
Medicare sequestration
Revenue Exposure

2% Medicare payment reduction through early federal FY2033 directly reduces Medicare revenue.

Relevance 85·Dependency 70·Confidence 95
Source evidence
“resulting in a 2% reduction in Medicare payments that extends through the first five months of federal fiscal year 2033”
Medicaid state directed and supplemental payment programs
Revenue Exposure

Approximately $6.2 billion of 2025 revenues came from Medicaid state directed and supplemental payment programs; changes to these programs are a flagged risk.

Relevance 85·Dependency 60·Confidence 94
Source evidence
“Our revenues from Medicaid state directed and supplemental payment programs totaled approximately $6.2 billion and $5.5 billion in 2025 and 2024, respectively.”
Expiration of enhanced premium tax credits (EPTCs)
Regulatory Exposure

EPTC expiration at end of 2025 is expected to reduce Exchange enrollment, reducing privately insured patient volumes and revenues.

Relevance 85·Dependency 60·Confidence 93
Source evidence
“including the expiration at the end of 2025 of enhanced premium tax credits ("EPTCs") for eligible individuals purchasing insurance coverage through federal and state-based health insurance marketplaces”
Physician recruitment and alignment
Demand Driver

Number and quality of affiliated/employed physicians drive patient referrals and competitive position; competitors deploy physician alignment strategies like employing physicians and acquiring practices.

Relevance 82·Dependency 70·Confidence 88
Source evidence
“Our hospitals face competitors that are implementing physician alignment strategies, such as employing physicians, acquiring physician practice groups and participating in ACOs or other clinical integration models.”
2025 Federal Budget Act (FBA)
Regulatory Exposure

FBA provisions are expected to impact coverage obtained through the Exchanges, contributing to potential declines in privately insured patient volumes.

Relevance 80·Dependency 55·Confidence 90
Source evidence
“provisions of the FBA that are expected to impact coverage obtained through the Exchanges”
Healthcare labor availability and wage growth
Cost Driver

Personnel-related capacity constraints, wage increases and ability to retain nurses, physicians and technical personnel are flagged operational risks.

Relevance 75·Dependency 60·Confidence 90
Source evidence
“personnel-related capacity constraints, increases in wages and the ability to attract, utilize and retain qualified management and other personnel, including affiliated physicians, nurses and medical and technical support personnel”
Freestanding ASCs and specialty hospitals
Competitive Exposure

Growing number of freestanding specialty hospitals, surgery centers, urgent care and imaging facilities competes for patients, particularly in high-margin services.

Relevance 72·Dependency 60·Confidence 88
Source evidence
“We also face competition from specialty hospitals and from both our own and unaffiliated freestanding ASCs for market share in certain high margin services.”
Mandatory nurse-staffing ratios
Cost Driver

Existing and potential nurse-staffing ratio mandates in operating states could significantly increase labor costs and constrain admissions.

Relevance 70·Dependency 60·Confidence 90
Source evidence
“our compliance with such measures could significantly affect labor costs and have an adverse impact on revenues or our results of operations if we are required to limit admissions”
State certificate of need (CON) laws
Legal Exposure

CON laws restrict facility expansion and capex but also restrict competition; removal could reduce barriers to entry in HCA's service areas.

Relevance 70·Dependency 60·Confidence 88
Source evidence
“Removal of these requirements could reduce barriers to entry and increase competition in our service areas.”
Inflation and macroeconomic conditions
Cost Driver

Business results may suffer during periods of significant inflation per macroeconomic risk factors, amid rising costs and strong competition for patients.

Relevance 68·Dependency 55·Confidence 85
Source evidence
“Our overall business results may suffer during periods of significant inflation, gener”
340B Drug Pricing Program payment reductions
Revenue Exposure

CMS outpatient PPS payment reductions tied to the 340B program reduce Medicare outpatient payments from CY2026 onward for several years.

Relevance 65·Dependency 55·Confidence 90
Source evidence
“additional reductions to payments for non-drug item and services took effect in calendar year 2026 and will continue for several years”
Tariffs and trade barriers
Cost Driver

Tariffs and trade barriers are cited as potential sources of increased expenses and pharmaceutical/supply chain disruptions.

Relevance 60·Dependency 40·Confidence 88
Source evidence
“supply and pharmaceutical shortages and disruptions (including as a result of tariffs or geopolitical disruptions)”
Tariffs and trade policy
Cost Driver

Changes in trade policy and new or increased tariffs may impact the company's supply chain operations and costs.

Relevance 55·Dependency 50·Confidence 88
Source evidence
“changes to trade policy and new or increased tariffs, which may impact our supply chain operations”
Full company information
Latest profile, trading, valuation, and identifier data stored for HCA.
Share price
$462.86
Market cap
$96.69B
Exchange
NYSE
Currency
USD
CEO
Samuel N. Hazen
Employees
320,000
IPO date
10/03/2011
Beta
1.11
Last dividend
$0.00
Day range
$461.85 – $470.36
52-week range
$353.99 – $556.52
1-day performance
-1.04%
1-year performance
30.76%
Current drawdown (1Y)
-16.83%
CIK
0000860730
CUSIP
40412C101
ISIN
US40412C1018
Created
07/12/2025, 04:29:36
Last update
04/11/2026, 07:59:31

Track HCA Healthcare, Inc. with an AI analyst

See which prediction-market events move HCA, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to HCA from your Railway `news_articles` table.